PL1969127T3 - Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji - Google Patents
Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacjiInfo
- Publication number
- PL1969127T3 PL1969127T3 PL06848864T PL06848864T PL1969127T3 PL 1969127 T3 PL1969127 T3 PL 1969127T3 PL 06848864 T PL06848864 T PL 06848864T PL 06848864 T PL06848864 T PL 06848864T PL 1969127 T3 PL1969127 T3 PL 1969127T3
- Authority
- PL
- Poland
- Prior art keywords
- biologically active
- recombinant methods
- active vitamin
- dependent proteins
- producing biologically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/04—Oxidoreductases acting on the CH-OH group of donors (1.1) with a disulfide as acceptor (1.1.4)
- C12Y101/04001—Vitamin-K-epoxide reductase (warfarin-sensitive) (1.1.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/0109—Peptidyl-glutamate 4-carboxylase (4.1.1.90)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75264205P | 2005-12-21 | 2005-12-21 | |
EP06848864.2A EP1969127B8 (en) | 2005-12-21 | 2006-12-21 | Method of producing biologically active vitamin k dependent proteins by recombinant methods |
PCT/US2006/048954 WO2007075976A2 (en) | 2005-12-21 | 2006-12-21 | Method of producing biologically active vitamin k dependent proteins by recombinant methods |
Publications (2)
Publication Number | Publication Date |
---|---|
PL1969127T3 true PL1969127T3 (pl) | 2014-11-28 |
PL1969127T5 PL1969127T5 (pl) | 2018-02-28 |
Family
ID=38051872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06848864T PL1969127T5 (pl) | 2005-12-21 | 2006-12-21 | Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji |
Country Status (11)
Country | Link |
---|---|
US (6) | US20080045453A1 (pl) |
EP (2) | EP1969127B8 (pl) |
JP (3) | JP5526332B2 (pl) |
AU (1) | AU2006331501B2 (pl) |
CA (1) | CA2633661C (pl) |
DK (1) | DK1969127T4 (pl) |
ES (1) | ES2503365T5 (pl) |
PL (1) | PL1969127T5 (pl) |
PT (1) | PT1969127E (pl) |
SI (1) | SI1969127T2 (pl) |
WO (1) | WO2007075976A2 (pl) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1670947B1 (en) | 2003-09-23 | 2015-04-01 | University Of North Carolina At Chapel Hill | Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin k epoxide reductase gene and warfarin dosage |
JP4777251B2 (ja) | 2003-10-14 | 2011-09-21 | バクスター・インターナショナル・インコーポレイテッド | ビタミンkエポキシド還元酵素複合体サブユニット1vkorc1、クマリンおよびその誘導体の治療標的 |
GB0324044D0 (en) * | 2003-10-14 | 2003-11-19 | Astrazeneca Ab | Protein |
EP1861499A4 (en) | 2005-03-15 | 2008-09-03 | Univ North Carolina | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACTIVE PROTEINS DEPENDENT ON VITAMIN K |
KR20130140221A (ko) | 2005-04-13 | 2013-12-23 | 아스트라제네카 아베 | 감마 카르복실화를 필요로 하는 단백질 생산용 벡터를 포함하는 숙주 세포 |
EP1969127B8 (en) † | 2005-12-21 | 2017-12-13 | Aptevo BioTherapeutics LLC | Method of producing biologically active vitamin k dependent proteins by recombinant methods |
EP2139499A4 (en) * | 2007-04-26 | 2010-05-05 | Inspiration Biopharmaceuticals | RECOMBINANT VITAMIN K-DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHOD FOR THE PRODUCTION THEREOF |
US8206967B2 (en) * | 2007-07-06 | 2012-06-26 | Medimmune Limited | Method for production of recombinant human thrombin |
DK3581650T3 (da) | 2008-09-15 | 2023-03-13 | Uniqure Biopharma B V | Faktor ix polypeptidmutant, anvendelse deraf og en fremgangsmåde til fremstilling deraf |
AU2010269072C9 (en) * | 2009-07-10 | 2014-09-18 | Csl Limited | Method of increasing the expression yield of vitamin K-dependent proteins |
MX2012003816A (es) * | 2009-10-01 | 2012-07-04 | Toto Ltd | Construccion de adn y procedimiento para la generacion de celulas cho recombinantes usando la misma. |
WO2011053738A1 (en) * | 2009-10-30 | 2011-05-05 | Inspiration Biopharmaceuticals, Inc. | Method of producing recombinant vitamin k dependent proteins |
WO2012088222A2 (en) | 2010-12-21 | 2012-06-28 | The University Of North Carolina At Chapel Hill | Methods and compositions for producing active vitamin k-dependent proteins |
JP2015507929A (ja) * | 2012-02-14 | 2015-03-16 | ポートラ ファーマシューティカルズ, インコーポレイテッド | 第Xa因子阻害剤に対する組み換え拮抗剤を製作するためのプロセス |
CA2904125C (en) * | 2013-03-12 | 2022-06-07 | Cmc Icos Biologics, Inc. | Improved recombinant protein expression using a hybrid chef1 promoter |
JP5830486B2 (ja) * | 2013-03-29 | 2015-12-09 | シスメックス株式会社 | 組換えバキュロウイルスおよびその利用 |
RU2585532C2 (ru) * | 2014-01-31 | 2016-05-27 | Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук"(ФИЦ Биотехнологии РАН) | Плазмида для экспрессии рекомбинантного фактора свёртываемости крови ix человека, клетка сно - продуцент рекомбинантного фактора свёртываемости крови ix человека и способ получения указанного фактора |
AU2016363789B2 (en) * | 2015-12-02 | 2022-06-02 | CSL Behring Lengnau AG | Improved media for the expression of recombinant vitamin K-dependent proteins |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4599308A (en) | 1981-10-06 | 1986-07-08 | Hamer Dean H | Protein from SV40 recombinants |
DE3380848D1 (en) | 1982-08-04 | 1989-12-21 | Nat Res Dev | Molecular cloning of the gene for human anti-haemophilic factor ix |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
FR2564106B1 (fr) | 1984-05-09 | 1988-04-22 | Transgene Sa | Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix. |
US4879236A (en) | 1984-05-16 | 1989-11-07 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US4745057A (en) | 1984-05-18 | 1988-05-17 | Eli Lilly And Company | Method, vectors and transformants for high expression of heterologous polypeptides in yeast |
WO1985005376A1 (fr) | 1984-05-22 | 1985-12-05 | Transgene S.A. | Vecteurs d'expression du facteur ix et lignees cellulaires produisant le facteur ix actif |
US4912038A (en) | 1984-12-11 | 1990-03-27 | California Biotechnology Inc. | Recombinant DNA sequence encoding alveolar surfactant protein |
US4879224A (en) | 1985-01-10 | 1989-11-07 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides |
US4761371A (en) | 1985-02-12 | 1988-08-02 | Genentech, Inc. | Insulin receptor |
DE3684546D1 (de) | 1985-04-22 | 1992-04-30 | Genetics Inst | Herstellung mit hoher leistung des aktivfaktors ix. |
FR2600334B1 (fr) | 1986-06-23 | 1989-05-12 | Transgene Sa | Vecteurs d'integration dans les cellules eucaryotes assurant l'expression du facteur ix, lignees celullaires obtenues et procede pour leur preparation |
US4877729A (en) | 1986-07-14 | 1989-10-31 | Genetics Institute, Inc. | Recombinant DNA encoding novel family of primate hematopoietic growth factors |
FR2638643B1 (fr) | 1988-11-09 | 1991-04-12 | Transgene Sa | Sequence d'adn codant pour le facteur ix humain ou une proteine analogue, vecteur d'expression, cellules transformees, procede de preparation du facteur ix et produits obtenus correspondants |
JPH05508551A (ja) * | 1990-07-23 | 1993-12-02 | ザイモジェネティクス,インコーポレイティド | ガンマーカルボキシラーゼおよび使用の方法 |
ATE158816T1 (de) * | 1990-11-26 | 1997-10-15 | Genetics Inst | Expression von pace in wirtszellen und verfahren zu dessen verwendung |
US5965789A (en) * | 1991-01-11 | 1999-10-12 | American Red Cross | Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals |
US5268275A (en) * | 1991-05-08 | 1993-12-07 | The University Of North Carolina At Chapel Hill | Vitamin K-dependent carboxylase |
US5714583A (en) | 1995-06-07 | 1998-02-03 | Genetics Institute, Inc. | Factor IX purification methods |
US5888809A (en) * | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
WO2000054787A1 (en) | 1999-03-16 | 2000-09-21 | The Children's Hospital Of Philadelphia | Enhanced gamma-carboxylation of recombinant vitamin k-dependent clotting factors |
HUP0301245A3 (en) * | 2000-10-02 | 2005-12-28 | Novo Nordisk Healthcare Ag | Tmethod for the production of vitamin k-dependent proteins |
EP1670947B1 (en) * | 2003-09-23 | 2015-04-01 | University Of North Carolina At Chapel Hill | Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin k epoxide reductase gene and warfarin dosage |
GB0324044D0 (en) * | 2003-10-14 | 2003-11-19 | Astrazeneca Ab | Protein |
WO2006063292A1 (en) † | 2004-12-08 | 2006-06-15 | Icos Corporation | Recombinant method for making multimeric proteins |
EP1831363A1 (en) * | 2004-12-21 | 2007-09-12 | Novo Nordisk Health Care AG | Expression of gamma-carboxylated polypeptides in gamma-carboxylation deficient host systems |
CN101124320A (zh) * | 2005-02-28 | 2008-02-13 | 巴克斯特国际公司 | 重组共表达维生素k环氧化物还原酶亚基1以提高依赖维生素k的蛋白质表达 |
EP1861499A4 (en) * | 2005-03-15 | 2008-09-03 | Univ North Carolina | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACTIVE PROTEINS DEPENDENT ON VITAMIN K |
KR20130140221A (ko) * | 2005-04-13 | 2013-12-23 | 아스트라제네카 아베 | 감마 카르복실화를 필요로 하는 단백질 생산용 벡터를 포함하는 숙주 세포 |
EP1969127B8 (en) † | 2005-12-21 | 2017-12-13 | Aptevo BioTherapeutics LLC | Method of producing biologically active vitamin k dependent proteins by recombinant methods |
-
2006
- 2006-12-21 EP EP06848864.2A patent/EP1969127B8/en active Active
- 2006-12-21 PT PT68488642T patent/PT1969127E/pt unknown
- 2006-12-21 US US11/643,563 patent/US20080045453A1/en not_active Abandoned
- 2006-12-21 JP JP2008547588A patent/JP5526332B2/ja active Active
- 2006-12-21 AU AU2006331501A patent/AU2006331501B2/en not_active Ceased
- 2006-12-21 DK DK06848864.2T patent/DK1969127T4/en active
- 2006-12-21 EP EP11157194A patent/EP2385125A3/en not_active Withdrawn
- 2006-12-21 CA CA2633661A patent/CA2633661C/en active Active
- 2006-12-21 ES ES06848864.2T patent/ES2503365T5/es active Active
- 2006-12-21 PL PL06848864T patent/PL1969127T5/pl unknown
- 2006-12-21 WO PCT/US2006/048954 patent/WO2007075976A2/en active Application Filing
- 2006-12-21 SI SI200631827T patent/SI1969127T2/sl unknown
-
2012
- 2012-11-19 US US13/681,021 patent/US20130266982A1/en not_active Abandoned
-
2013
- 2013-07-26 JP JP2013155589A patent/JP2013223514A/ja not_active Revoked
-
2015
- 2015-04-13 US US14/685,262 patent/US20160108449A1/en not_active Abandoned
-
2016
- 2016-11-21 JP JP2016225684A patent/JP2017046717A/ja active Pending
-
2018
- 2018-01-19 US US15/875,373 patent/US20190032101A1/en not_active Abandoned
-
2020
- 2020-06-02 US US16/889,986 patent/US20210095323A1/en not_active Abandoned
-
2022
- 2022-10-20 US US17/970,051 patent/US20230287471A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230287471A1 (en) | 2023-09-14 |
WO2007075976A2 (en) | 2007-07-05 |
JP2013223514A (ja) | 2013-10-31 |
SI1969127T1 (sl) | 2014-12-31 |
JP2017046717A (ja) | 2017-03-09 |
JP5526332B2 (ja) | 2014-06-18 |
DK1969127T3 (da) | 2014-09-22 |
EP2385125A2 (en) | 2011-11-09 |
DK1969127T4 (en) | 2017-10-16 |
EP1969127B8 (en) | 2017-12-13 |
WO2007075976A3 (en) | 2007-10-04 |
ES2503365T5 (es) | 2017-10-31 |
US20130266982A1 (en) | 2013-10-10 |
PL1969127T5 (pl) | 2018-02-28 |
SI1969127T2 (sl) | 2017-10-30 |
CA2633661A1 (en) | 2007-07-05 |
US20210095323A1 (en) | 2021-04-01 |
CA2633661C (en) | 2019-06-04 |
EP2385125A3 (en) | 2012-04-11 |
ES2503365T3 (es) | 2014-10-06 |
US20160108449A1 (en) | 2016-04-21 |
JP2009521224A (ja) | 2009-06-04 |
EP1969127B1 (en) | 2014-06-18 |
EP1969127A2 (en) | 2008-09-17 |
US20190032101A1 (en) | 2019-01-31 |
EP1969127B2 (en) | 2017-07-12 |
US20080045453A1 (en) | 2008-02-21 |
AU2006331501A1 (en) | 2007-07-05 |
PT1969127E (pt) | 2014-09-23 |
AU2006331501B2 (en) | 2013-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1969127T5 (pl) | Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji | |
EP1748077A4 (en) | PROCESS FOR PROTEIN PRODUCTION | |
EP1901820A4 (en) | PROCESS FOR REDUCING THE CONDITION OF PROTEINS RELATED TO DISEASES | |
IL207957A (en) | A method for making protein-based medical molecules | |
IL182626A0 (en) | Methods for refolding of recombinant antibodies | |
IL190550A0 (en) | Methods of protein production using anti-senescence compounds | |
ZA200701672B (en) | Production of tnfr-ig fusion protein | |
HK1070386A1 (en) | Methods for production of recombinant urokinase | |
EP1894235A4 (en) | METHOD FOR PRODUCING AN ELECTRODE | |
EP1930428A4 (en) | HOST YEAST, TRANSFORMATION AGENT AND PROCESS FOR PRODUCING FOREIGN PROTEIN | |
EP2183981A4 (en) | PROCESS FOR PRODUCING SOLUBLE SOY PROTEINS IN AN ACIDIC ENVIRONMENT | |
WO2007103447A3 (en) | A method for the preparation of recombinant human thrombin | |
EP1995254A4 (en) | PROCESS FOR PRODUCING PEPTIDE | |
PL1835816T3 (pl) | Sposób wytwarzania hydrolizatów białkowych | |
GB0426160D0 (en) | Production of proteins | |
ZA200711011B (en) | A recombinant method for production of an erythropoiesis stimulating protein | |
EP1870460A4 (en) | PROCESS FOR PREPARING PROTEINS WITH TRIPELHELIX STRUCTURE | |
IL183106A0 (en) | Production of proteins | |
EP2062974A4 (en) | PROCESS FOR PREPARING FUSION PROTEIN | |
GB0412186D0 (en) | Production of recombinant protein | |
TWI347975B (en) | Method of producing recombinant protein | |
EP1760149A4 (en) | PROCESS FOR CONSTRUCTING MODIFIED PROTEIN | |
HK1112254A1 (en) | Method of producing protein by using hamster igf-1 | |
EP1882743A4 (en) | PROCESS FOR PRODUCING A PROTEIN | |
EP2494040A4 (en) | PROCESS FOR PRODUCING RECOMBINANT VITAMIN K-DEPENDENT PROTEINS |